Erythromycin ethyl succinate 500mg/5ml oral suspension sugar free

Pajjiż: Ingilterra

Lingwa: Ingliż

Sors: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredjent attiv:

Erythromycin ethyl succinate

Disponibbli minn:

Pinewood Healthcare

Kodiċi ATC:

J01FA01

INN (Isem Internazzjonali):

Erythromycin ethyl succinate

Dożaġġ:

100mg/1ml

Għamla farmaċewtika:

Oral suspension

Rotta amministrattiva:

Oral

Klassi:

No Controlled Drug Status

Tip ta 'preskrizzjoni:

Valid as a prescribable product

Sommarju tal-prodott:

BNF: 05010500; GTIN: 5099186003108

Karatteristiċi tal-prodott

OBJECT 1
ERYTHROMYCIN ETHYL SUCCINNATE 500 MG/5 ML
GRANULES FOR ORAL SUSPENSION
Summary of Product Characteristics Updated 28-Mar-2018 | Pinewood
Healthcare
1. Name of the medicinal product
Erythromycin ethyl succinate 500 mg/5 ml Granules for Oral suspension
2. Qualitative and quantitative composition
Erythromycin ethylsuccinate EP 500 mg/5 ml
(where each mg of base is taken to be equivalent to 1000 units of
activity)
Excipients with known effect
Each 5 ml of oral suspension contains 51.91 mg of sodium.
Each 5 ml of oral suspension contains 2.725 g of sucrose.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Granules for Oral Suspension
4. Clinical particulars
4.1 Therapeutic indications
Antibiotic for treatment of infections caused by erythromycin
sensitive organisms especially gram
positive pyogenic cocci and some gram-negative bacteria. It may be
used in a wide variety of clinical
infections
Erythromycin is an appropriate alternative to penicillin in
hypersensitive patients especially in pre or post
operative patients.
Respiratory Tract Infections:
Acute and chronic bronchitis, Legionnaire's disease, tracheitis,
bronchiectasis, pneumonia
Skin and Soft Tissue Infections:
Acute infections of skin and soft tissue which are mild to moderately
severe
Eye/Ear Infections:
Otitis media and otitis externa mastoiditis, chlamydial
conjunctivitis, blepharitis
Oral Infections:
Gingivitis, Vincent's angina
Gastro-Intestinal Infections:
Staphylococcal enterocolitis, cholecystitis, campylobacter infections
Other Infections:
Gonorrhoea, syphilis, urethritis, diphtheria, pertussis
4.2 Posology and method of administration
Method of Administration
Oral
Posology
Adults and Children over 8 Years
For mild to moderate infections 2 g daily in divided doses up to 4 g
daily in severe infections;
250-500 mg every 6 hours or 0.5-1 g every 12 hours.
For acne vulgaris the usual dose is 250 mg three times daily before
meals for one to four weeks and then
reduced to twice daily until improvement occurs.
Children Aged